These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3970553

  • 1. [A study on the correlation between the concentration of antitumor agent and the clinical effect. An experience with THP-ADM].
    Ogawa A, Yamashita K.
    Gan To Kagaku Ryoho; 1985 Feb; 12(2):303-8. PubMed ID: 3970553
    [Abstract] [Full Text] [Related]

  • 2. [THP-adriamycin in head and neck tumor].
    Honda T, Ohyama W, Sonoda T, Uchida K, Hirokawa T, Takada K, Takeda C.
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2538-44. PubMed ID: 6651307
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic and pharmacodynamic advantages of pirarubicin over adriamycin after intraarterial hepatic administration in the rabbit VX2 tumor model.
    Munck JN, Riggi M, Rougier P, Chabot GG, Ramirez LH, Zhao Z, Bognel C, Ardouin P, Herait P, Gouyette A.
    Cancer Res; 1993 Apr 01; 53(7):1550-4. PubMed ID: 8453622
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacokinetic studies on THP-ADM (tetrahydropyranyl adriamycin)].
    Majima H.
    Gan To Kagaku Ryoho; 1987 Mar 01; 14(3 Pt 2):865-70. PubMed ID: 3566297
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacokinetic studies of THP-ADM (tetrahydropyranyl adriamycin)].
    Majima H, Iguchi H, Tone H.
    Gan To Kagaku Ryoho; 1986 Mar 01; 13(3 Pt 1):542-8. PubMed ID: 3954376
    [Abstract] [Full Text] [Related]

  • 6. [Comparative studies on the pharmacokinetics between THP and adriamycin in the same patients].
    Nakajima O, Imamura Y, Matsumoto A, Koyama Y, Shomura T, Kawamura K, Murata S.
    Gan To Kagaku Ryoho; 1986 Feb 01; 13(2):261-70. PubMed ID: 3947106
    [Abstract] [Full Text] [Related]

  • 7. 4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent.
    Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1982 Apr 01; 42(4):1462-7. PubMed ID: 7060020
    [Abstract] [Full Text] [Related]

  • 8. [Preliminary phase II clinical study of 4'-O-tetrahydropyranyl doxorubicin (THP-ADM)].
    Majima H.
    Gan To Kagaku Ryoho; 1983 Mar 01; 10(3):805-10. PubMed ID: 6882000
    [Abstract] [Full Text] [Related]

  • 9. [Postoperative treatment for malignant intracranial tumors--especially concerning intermittent intra-carotid administration of adriamycin].
    Sakai N, Kondo H, Shikinami A, Hirata T, Funakoshi T, Tanabe Y, Yamada H.
    No Shinkei Geka; 1984 Mar 01; 12(3 Suppl):237-43. PubMed ID: 6462330
    [Abstract] [Full Text] [Related]

  • 10. [A phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with head and neck cancer].
    Takeda C.
    Gan To Kagaku Ryoho; 1986 May 01; 13(5):1970-9. PubMed ID: 3707155
    [Abstract] [Full Text] [Related]

  • 11. [Multi-institutional cooperative study on combination chemotherapy with THP, CDDP and 5-FU for squamous cell carcinoma of the head and neck].
    Urade M, Yanagisawa T, Kishimoto H, Yoshioka W, Teranobu O, Shigeta Y, Komori T, Shimada K, Ohnishi M, Tanaka Y, Kamiya Y, Akazawa N, Oko T, Takahashi N, Adachi R, Tanigaki S, Hirata Y, Yakushiji N, Kitamura R, Hashikawa N, Hyogo Oncology Group for Oromaxillary Tumors.
    Gan To Kagaku Ryoho; 2001 Jun 01; 28(6):789-95. PubMed ID: 11432346
    [Abstract] [Full Text] [Related]

  • 12. [Combined CDDP-THP-PEP chemotherapy (PTP therapy) for head and neck squamous cell carcinoma--a group study].
    Sugasawa M, Nibu K, Ichimura K, Kaga K, Asai M, Senba T, Yamasoba T, Tsunoda K, Abe K, Kobayashi T.
    Gan To Kagaku Ryoho; 1994 Jun 01; 21(7):969-74. PubMed ID: 8002635
    [Abstract] [Full Text] [Related]

  • 13. [Basic and clinical evaluation of the effect of pirarubicin against head and neck cancer--chemosensitivity test and a comparative study with doxorubicin].
    Nakashima T, Masuda A, Yano G, Maehara Y.
    Gan To Kagaku Ryoho; 1994 Apr 01; 21(5):633-9. PubMed ID: 8154889
    [Abstract] [Full Text] [Related]

  • 14. [New management of brain neoplasms. 2. Local injection of adriamycin].
    Nakazawa S, Itoh Y, Shimura T, Matsumoto M, Yajima K.
    No Shinkei Geka; 1983 Aug 01; 11(8):821-7. PubMed ID: 6314166
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of preoperative intra-arterial infusion of adriamycin on locally advanced breast cancer].
    Morimoto T, Yamamoto H, Yamakawa T, Mitsuyama N, Inui K, Komaki K, Umemoto A, Akaiwa T, Monden Y.
    Gan To Kagaku Ryoho; 1985 Aug 01; 12(8):1599-605. PubMed ID: 4026329
    [Abstract] [Full Text] [Related]

  • 17. [Chemosensitivity testing of anticancer agents in head and neck tumors. I: Comparison between head and neck squamous cell cancers and thyroid cancers].
    Nakashima T, Tomita K, Kuratomi Y, Maehara Y, Kohnoe S.
    Gan To Kagaku Ryoho; 1990 Jan 01; 17(1):79-84. PubMed ID: 2297240
    [Abstract] [Full Text] [Related]

  • 18. [Intra-arterial infusion of adriamycin in the treatment of locally advanced breast cancer].
    Yayoi E, Inaji H, Maeura Y, Mori T, Takatsuka Y.
    Gan To Kagaku Ryoho; 1984 Dec 01; 11(12 Pt 2):2751-9. PubMed ID: 6508325
    [Abstract] [Full Text] [Related]

  • 19. [Tissue levels of pirarubicin (THP) in dogs following intra-arterial infusion].
    Sumiyoshi Y, Yokota K, Akiyama M, Kawaoto H, Kosugi I.
    Gan To Kagaku Ryoho; 1991 Aug 01; 18(10):1621-6. PubMed ID: 1872619
    [Abstract] [Full Text] [Related]

  • 20. [Preoperative concurrent chemoradiotherapy with intra-arterial infusion of pirarubicin and continuous intravenous instillation of 5-fluorouracil for resectable advanced head and neck squamous cell carcinoma].
    Iguchi H, Kusuki M, Nakamura A, Nishiura H, Kanazawa A, Yamane H.
    Gan To Kagaku Ryoho; 2003 Mar 01; 30(3):391-7. PubMed ID: 12669399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.